HLA-B alleles confer susceptibility to sulfasalazine-induced severe cutaneous adverse reactions
Journal of Allergy and Clinical Immunology · 2026
DOI: 10.1016/j.jaci.2026.04.017 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026. Verfasst von Chuang-Wei Wang und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taipei, and Keelung, Taiwan; Can…. Hauptthemen laut MEDLINE: Sulfasalazine, HLA-B Antigens, Stevens-Johnson Syndrome, Antirheumatic Agents. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chang Gung Memorial Hospital, National Science and Technology Council.
Abstract (Originalsprache)
BACKGROUND: Sulfasalazine is a disease-modifying antirheumatic drug used to treat arthritis and ankylosing spondylitis. However, it may cause life-threatening severe cutaneous adverse reactions (SCARs), including Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms. OBJECTIVE: Genetic predisposition to sulfasalazine-induced SCARs was assessed. METHODS: This multicountry genetic study involved discovery, replication, and meta-analysis cohorts. The discovery cohort comprised 62 cases of sulfasalazine-induced SCARs and 75 sulfasalazine-tolerant subjects as well as 657 population controls from China and Taiwan who underwent whole-exome sequencing. The replication cohort comprised additional 17 cases and 2038 population controls from Taiwan who underwent HLA genotyping. The meta-analysis cohort comprised a total of 105 cases from Japan, Thailand, Malaysia, Taiwan, and China, together with 23,743 country-matched population controls. Functional immune mechanisms were explored with ex vivo lymphocyte activation assays. RESULTS: In the discovery cohort, rs9266217 in HLA-B exhibited the strongest association. HLA genotyping in replication cohort and phenotype stratification found 4 HLA-B alleles that jointly yielded 84.8% sensitivity (P = 2.3 × 10-24) in predicting sulfasalazine-induced SCARs in the Chinese population. Meta-analysis across 4 Asian countries confirmed significant associations for 3 alleles. Functional assays showed that sulfasalazine or its active metabolite, sulfapyridine, markedly increased granulysin release from CD8+ T cells of affected patients, supporting an HLA-restricted reaction. CONCLUSION: Multiple HLA-B alleles (B∗39:01, B∗13:01, and B∗38:02) are strongly associated with sulfasalazine-induced SCARs in Asians.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taipei, and Keelung, Taiwan; Cancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung Memori…
- Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taipei, and Keelung, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, Xiamen, China; Col…
- Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
- Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou, Taipei, and Keelung, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan.
- Department of Dermatology, Chung Shan Medical University Hospital, Taichung, Taiwan; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
- Cancer Vaccine and Immune Cell Therapy Core Laboratory, Chang Gung Memorial Hospital, Linkou, Taiwan; Institute of Pharmacology, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Förderung
- Chang Gung Memorial Hospital
- National Science and Technology Council
Zitieren
APA
Wang, C. W., Chen, W. T., Chen, C. B., Chu, C. Y., Chung-Yee Hui, R., Lu, C. W., Chiu, T. M., Hung, S. I., Huei, H. Y., Tassaneeyakul, W., Choon, S. E., Nakkam, N., Sukasem, C., Jan Wu, Y. J., Chung, H. Y., Lung, J. H., Chang, J. S., Lee, Y. S., Chang, Y. C., …, & Taiwan/Asian Severe Cutaneous Adverse Reaction Consortium (2026). HLA-B alleles confer susceptibility to sulfasalazine-induced severe cutaneous adverse reactions. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2026.04.017
Vancouver
Wang CW, Chen WT, Chen CB, Chu CY, Chung-Yee Hui R, Lu CW, et al. HLA-B alleles confer susceptibility to sulfasalazine-induced severe cutaneous adverse reactions. Journal of Allergy and Clinical Immunology. 2026. doi:10.1016/j.jaci.2026.04.017
BibTeX
@article{Wang2026,
author = {Wang, Chuang-Wei and Chen, Wei-Ti and Chen, Chun-Bing and Chu, Chia-Yu and Chung-Yee Hui, Rosaline and Lu, Chun-Wei and Chiu, Tsu-Man and Hung, Shuen-Iu and Huei, Huang Yu and Tassaneeyakul, Wichittra and Choon, Siew-Eng and Nakkam, Nontaya and Sukasem, Chonlaphat and Jan Wu, Yeong-Jian and Chung, Hsin-Yu and Lung, Jr-Hau and Chang, Jeng-Shou and Lee, Yun-Shien and Chang, Ya-Ching and Yu, Kuang-Hui and Teng, Yu-Chuan and Lin, Shang-Hung and Lai, Kuo-Chu and Hou, Hsin-Han and Wu, Jennifer and Chi, Min-Hui and Lee, Hua-En and Yu-Wei Lin, Yang and Lin, Yu-Jr and Chung, Wen-Hung and Taiwan/Asian Severe Cutaneous Adverse Reaction Consortium, Taiwan/Asian Severe Cutaneous Adverse Reaction Consortium},
title = {HLA-B alleles confer susceptibility to sulfasalazine-induced severe cutaneous adverse reactions},
journal = {Journal of Allergy and Clinical Immunology},
year = {2026},
doi = {10.1016/j.jaci.2026.04.017}
}
EUVIMED